ROC AUC | Sens | Spec | PPV | NPV | LR + | LR- | |
---|---|---|---|---|---|---|---|
Before POCUS | |||||||
Acute heart failure (valid* n = 185) | 0.72 (0.66–0.78) | 57.5% (46–68) | 86.7% (79–93) | 76.7% (64–87) | 72.8% (64–80) | 4.31 (2.56–7.27) | 0.49 (0.38–0.64) |
AE-COPD/AE-asthma (valid* n = 202) | 0.87 (0.82–0.91) | 93.8% (85–98) | 80.3% (72.6–86.6) | 68.2% (57–78) | 96.5% (91–99) | 4.62 (3.3–6.47) | 0.08 (0.03–0.2) |
Pneumonia (valid* n = 172) | 0.67 (0.59–0.76) | 57.5% (41–73) | 77.3% (69–84) | 43.4% (30–58) | 85.7% (78–92) | 2.53 (1.68–3.82) | 0.55 (0.38–0.8) |
Pulmonary embolism (valid* n = 167) | 0.66 (0.42–0.90) | 40.0% (5–85) | 92% (87–96) | 13.3% (2–41) | 98.0% (94–100) | 4.98 (1.51–16.44) | 0.65 (0.32–1.34) |
Pneumothorax (valid* n = 183) | 0.72 (0.23–1.0) | 50.0% (1–99) | 93.4% (89–97) | 7.7% (0–36) | 99.4% (97–100) | 7.54 (1.7–33.46) | 0.54(0.13–2.14) |
After POCUS | |||||||
Acute heart failure (valid* n = 194) | 0.79 (0.73–0.84) | 65.0% (54–75) | 92.1% (86–96) | 85.2% (74–93) | 78.9% (71–86) | 8.23 (4.31–15.73) | 0.38 (0.28–0.51) |
AE-COPD/AE-asthma (valid* n = 200) | 0.93 (0.88–0.97) | 90.3% (80–96) | 94.9% (90–98) | 88.9% (78–95) | 95.6% (91–98) | 17.81 (8.61–36.82) | 0.1 (0.05–0.22) |
Pneumonia (valid* n = 170) | 0.66 (0.58–0.74) | 50% (35–65) | 82.5% (75–89) | 50% (35–65) | 82.5% (75–89) | 2.86 (1.77–4.63) | 0.61 (0.45–0.82) |
Pulmonary embolism (valid* n = 187) | 0.61 (0.37–0.86) | 25.0% (1–81) | 97.8% (95–99) | 20.0% (1–72) | 98.4% (95–100) | 11.44 (1.62–80.76) | 0.77 (0.44–1.35) |
Pneumothorax (valid* n = 210) | 0.75 (0.26–1.0) | 50.0% (1–99) | 99.5% (97–100) | 50% (1–99) | 99.5% (97–100) | 104 (9.47–1142.53) | 0.50 (0.13–2.01) |